2023 Preanalytical Conference

Implementing Preanalytical Tools That Improve Patient Care
  • Start Date
    Oct 20, 2023
  • End Date
    Oct 21, 2023
  • CE Credits
    Up to 10.0 ACCENT Credits
  • Duration
    1.5 days

The Association for Diagnostics & Laboratory Medicine’s (formerly AACC) Preanalytical Phase conference committee issued a call for poster abstracts. Authors of accepted abstracts will be invited to display their poster(s) during the meeting and must register to do so. Authors who register and present their posters in-person will have the abstract published in the Association for Diagnostics & Laboratory Medicine’s (ADLM) online peer-reviewed publication The Journal of Applied Laboratory Medicine (JALM). All poster abstract submissions must be made electronically through ADLM’s online poster abstract submission form (linked below) to be considered. The submission deadline was August 11, 2023 and authors whose abstracts are accepted will be notified by August 30, 2023.

All submitted abstracts will be reviewed for clarity, scientific impact, and integrity. Abstracts should cover topics across the preanalytical phase cycle.

Key Dates and Deadline

  • The deadline for submission was August 11, 2023
  • Acceptance notices will be sent by August 30, 2023
  • Authors of accepted abstract must confirm participation by September 11, 2023
  • ADLM’s Preanalytical Phase Conference will be held October 20-21, 2023

List of Scientific Poster Abstracts

Poster presentations will be on display from 8 a.m. to 5:30 p.m. on Friday, October 20.

  1. Improved Collection Practices for Blood Cultures Through Targeted Education of the Collection Staff in the Emergency Department
    Dejan Nikolic, Cooper University Health Care, Camden, NJ (United States)
  2. A “Positive” Move: Implementation of Positive Patient Identification Devices in a Large Healthcare System in Canada
    Junyan Shi, Vancouver General Hospital, Vancouver, BC (Canada)
  3. Evaluation of a Novel Capillary Blood Collection System for Reduced Hemolysis
    Scott Wentzell, BD, Franklin Lakes, NJ (United States)
  4. An Assessment of Individual Preference for a Novel Capillary Blood Collection System
    Bilal Abdallah, BD, Franklin Lakes, NJ (United States)
  5. Dynamic Tools to Address the Potential Financial Impact of Preanalytical Errors and Poor Specimen Quality
    Bilal Abdallah, BD, Franklin Lakes, NJ (United States)
  6. Right Test, Right Time: Reducing Inappropriate Test Orders and Improving Provider Experience Through Electronic Order Alerts
    Deanna Franke, Advocate Health - Atrium Health, Southeast Region, Charlotte, NC (United States)
  7. Use of Dried Serum and Blood Spots for Common Screening Tests on the Roche Cobas 8000
    Mohammad-Zaman Nouri, Access Genetics, Eden Prairie, MN (United States)
  8. Improving Meaningful Use for Body Fluid Orders
    Emily Ryan, Atrium Health, Macon, GA (United States)
  9. Impact and Frequency of IV Fluid Contamination on Basic Metabolic Panel Results Using Quality Metrics
    Nicholas Spies, Washington University School of Medicine, Saint Louis, MO (United States)
  10. *Automating the Retrospective Identification of IV Fluid Contamination in Basic Metabolic Panel Results with Machine Learning
    Nicholas Spies, Washington University School of Medicine, Saint Louis, MO (United States)
  11. Delta Check Performance Assessment by Using Real-World Data at the Temple University Health System
    Melissa Ulas, Temple University Hospital, Philadelphia, PA (United States)
  12. Hemolysis Rates Assessed by Index Versus Test Comment: Is One Approach Better Than Another?
    Paul Yip, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON (Canada)
  13. Preanalytical Phase Errors Constitute the Vast Majority of Errors in Clinical Laboratory Testing
    Yanchun Lin, Washington University School of Medicine in St. Louis, St Louis, MO (United States)
  14. Impact of Blood Collection Devices and Mode of Transportation on Peripheral Venous Blood Gas Parameters
    Raffick Bowen, Stanford University, Palo Alto, CA (United States)
  15. Impact of Autonomous Mobile Robot on Specimen Distribution Turnaround Time and Efficiency
    Jun Yi Ong, Singapore General Hospital, Singapore (Singapore)
  16. Advances in Centrifugation and Thermal Shipper Devices Enabling At-home Liquid Blood Specimen Collection
    Greg Sommer, Labcorp, Maple Grove, MN (United States)
  17. Investigating the Effects of Accelerometry, Time and Temperature of Pneumatic Tube Systems on Blood Specimens
    Ivan Stevic, London Health Sciences Centre and Western University, London, ON (Canada)
  18. Benchtop Centrifugation: An Effective Method for the Reducing Lipaemic Associated Interference in Grossly Lipaemic Samples?
    James Hall, Worthing Hospital, Worthing,  (United Kingdom)
  19. The Use of Microcentrifugation in Place of Ultracentrifugation to Reduce Lipaemia in Serum/Plasma Samples
    Win Chyn Laguio, University Hospitals Sussex NHS Foundation Trust, Brighton (United Kingdom)
  20. Effects of Hemolysis, Icterus, and Lipemia on 20 Chemistry Tests Performed in Body Fluid Specimens Measured on the Beckman Coulter AU5800
    Kyle Reed, The Ohio State University Wexner Medical Center, Columbus, OH (United States)
  21. An Evaluation of Contrast Media Interference on Cobas Pro Systems
    William Turgeon, Sherbrooke University, Sherbrooke, QC (Canada)
  22. Evaluation of Preanalytical Phase Techniques to Prepare Clotted Bloods for LC-MS/MS Analysis
    Noah Clark, NMS Labs, Horsham, PA (United States)
  23. Improved Turn-Around Time as a Result of Streamlining the PT/INR Testing
    Monica Ianosi-Irimie, Cooper University Hospital, Camden, NJ (United States)
  24. Performance Impacts During and After Installation of an Upgraded Preanalytical Automation System
    Claire Knezevic, Johns Hopkins University, Baltimore, MD (United States)
  25. Novel Portable Device for Direct-from-Blood Culture-free Diagnosis of Bloodstream Infections
    John Nobile, New England Hemolytics Inc., Branford, CT (United States)
  26. Impact of Specimen Type (Capillary & Venous) on Device Clinical Performance
    Samar Mahmoud, BD, Franklin Lakes, NJ (United States)
  27. *Urine Analysis of Calcium, Magnesium and Phosphorus: Preanalytical Considerations for the Elimination of the Acidification Step
    Daisy Unsihuay, Children's Hospital of Philadelphia, Wynnewood, PA (United States)
  28. Within-tube Stability of Selected Elements in BD Vacutainer® Trace Element K2EDTA and Serum Tubes
    Mitch Garcia, BD, Franklin Lakes, NJ (United States)
  29. Analyzing the Durability of Assays in Body Fluids, Serum, and Urine Preserved in Different Conditions
    Siddharth Khadkikar, MetroHealth, Cleveland, OH (United States)
  30. The Effect of Ambient Light Exposure on Total, Conjugated, and Unconjugated Bilirubin
    Amy Pyle-Eilola, Nationwide Children's Hospital, Columbus, OH (United States)
  31. Time, Insulin Concentration, and Sample Tube Type Play Critical Roles in Hemolysis-Mediated Insulin Degradation
    Emily Shang, Yale University, New Haven, CT (United States)
  32. *Denotes winner of the Student Poster Travel Award.

Poster Preparation Guidelines & Requirements

PRESENTATION REQUIREMENTS

Poster presenters are required to register for the conference, attend, and display and present their posters to be included in the JALM supplement. Poster abstracts will not be included in printed program materials unless the presenting author confirms their participation and registers by September 11. Please note, any requests to change the presenting author must be made in writing to [email protected] by September 7 for consideration.

WITHDRAWAL

If you plan to withdraw your abstract, please notify [email protected] in writing as soon as possible including the abstract title and author name.

POSTER SIZE AND DISPLAY BOARD

ADLM does not provide poster printing services. It is the responsibility of poster presenters to prepare and print their poster(s) for display on the provided poster boards. Please review the size and space information carefully as you prepare your poster.

  • The maximum size for an accepted poster is 46 inches (117 cm) x 46 inches (117 cm). If your poster exceeds the limit, it may be cut, folded, or otherwise modified to permit the allotted display room.
  • The poster abstract number provided by ADLM will be placed in the upper corner and measures 8.5 inches wide by 5.5 inches high (approximately 22 cm x 14 cm).

REQUIRED POSTER INFORMATION

Each accepted poster must contain the following information:

  • Title as submitted in your abstract submission.
  • Presenting author and all co-authors.
  • Author(s) affiliation(s).
  • Background of your study (why you did this work).
  • Method(s) used to achieve a solution.
  • Results obtained (figures, tables, etc.).
  • Conclusions and importance of your work to laboratory medicine.

Please note that ADLM only provides the poster abstract number placed in the upper corner. It is the responsibility of the poster presenter to print and display their poster(s) at the designated times.

GENERAL POSTER GUIDANCE

    Sample Collection

  • The information you display should have a professional appearance.
  • Instruments, components, and reagents are NOT permitted in the poster area.
  • All information should be easily read from at least 5 feet away from your poster.
    • Headings for abstract title and numbering for subsections should be a minimum of 72 pt font (approximately 1 inch or 2.5 cm height).
    • Subheadings should be a minimum of 36 pt font (approximately 0.5 inches or 1 cm height).
    • All type should be a minimum of 24 pt font (approximately 0.3 inches or 0.8 cm height) and readable from a distance of 5-7 feet (1.5-1.7 meters).

RESTRICTIONS

  • Instruments, components, or reagents are NOT permitted in the poster area.

POSTER SESSION SCHEDULE

Poster presentations will be on display from 8 a.m. to 5:30 p.m. on Friday, October 20. Please collect your badge at the registration table and identify your poster number for your spot at the poster presentation section.

Your poster is to remain on display for the entire day of the conference and removed Friday, October 20 at 5:30 p.m.

ADLM is not responsible for posters left on boards after the conference concludes.

Questions?

Email [email protected].